Vascugen Inc.

Vascular diseases afflict hundreds of millions of people worldwide. Many patients do not respond to standard treatments. We are developing regenerative medicines to address these unmet needs. Vascugen is dedicated to revolutionizing the standard of care for millions of patients suffering from severe conditions caused by restricted blood flow to tissues. Particularly for diabetic patients at high risk for limb amputation and associated morbidity. The company’s lead program is an induced-pluripotent stem cell (iPSC)-derived vasculogenic cell with the potential to forge new blood vessels in oxygen-starved tissues.